RCUS News
Archived Headlines
- US IPO Week Ahead: 1 biotech expected in the week ahead, 4 deals could launch starting Monday 03/02/18
- US IPO Week Ahead: 1 SPAC expected this week, and 9 IPOs to look for in March 02/23/18
- US IPO Weekly Recap: IPO market recovers in a week with 4 small deals 02/16/18
- Cancer immunotherapy biotech Arcus Biosciences files for $100 million IPO 02/16/18
US IPO Weekly Recap: Tech unicorn Zscaler pops 100%, Dropbox and Spotify up next
As expected, the year's first unicorn was a winner. Cybersecurity provider...read more
Arcus Biosciences prices upsized IPO at $15 high end
Arcus Biosciences, a clinical-stage biotech developing cancer immunotherapies, raised $120 million by offering 8 million shares at $15, the high end of the range of $13 to $15. Arcus Biosciences plans to list on the NYSE under the symbol RCUS. Citi, Goldman...read more
US IPO Week Ahead: Year's first unicorn leads a pickup in activity with 4 IPOs
The IPO market is back in session. The first unicorn of the year, Zscaler (ZS), headlines the week ahead featuring four companies that are targeting a combined $386 million. A strong debut could nudge forward a number of other software...read more
Immuno-oncology biotech Arcus Biosciences sets terms for $99 million IPO
Arcus Biosciences, a clinical-stage biotech developing cancer immunotherapies, announced terms for its IPO on Monday. The Hayward, CA-based company plans to raise $99 million by offering 7.1 million shares at a price range of $13 to $15. At the midpoint of...read more